Home LiteratureArticle Details
PMID: 2060184 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.

Clinical & experimental metastasis ·Vol. 9 ·No. 3 ·1991-00-00 ·Pages 259-72

Van Muijen GN, Cornelissen LM, Jansen CF, Figdor CG, Johnson JP, Bröcker EB, Ruiter DJ

Abstract

In order to study differences in antigen expression related to the different stages of the process of metastasis of human melanoma cell lines, we determined the expression pattern of a series of well-characterized genes in a set of human melanoma cell lines with different metastatic behavior in nude mice. This set included non-metastatic (IF6, 530), sporadically metastatic (M14, Mel 57), and frequently metastatic (BLM, MV3) cell lines after subcutaneous inoculation. To study the phenotype of these cell lines both the cultured cells and representative samples of local tumors at the inoculation site and their metastases in the lungs were immunostained with a panel of monoclonal antibodies directed against melanocytic differentiation or progression antigens. Although most cell lines (IF6, 530, M14 and Mel 57) showed HLA-DR expression in vitro, these antigens were lacking in all xenografted lesions studied with exception of the 530 cell line. 530 Xenografts, however, showed a dramatic down-regulation of HLA-DR compared with the cell line in vitro. The same phenomenon was seen with respect to ICAM-1 expression. The expression of all other antigens studied in xenografts, both in subcutaneous tumors and in lung lesions, was in general comparable to that in the melanoma cell lines in vitro, with exception of the 530 cell line. In all melanoma cell lines except 530 the degree of intra- and interlesional heterogeneity regarding the expression of all antigens studied was limited. Remarkably, comparison of the immunophenotype of the frequently metastasizing (BLM, MV3) and the sporadically (M14, Mel 57) or non-metastasizing (IF6, 530) cell lines showed that the two frequently metastasizing cell lines had marked expression of the progression antigens VLA-2 and epidermal growth factor receptor, and lack of expression of the differentiation antigen NKI-beteb. These findings warrant further studies on the role of these antigens in the process of metastasis of human melanoma cells in nude mice.

MeSH Terms
Adult Animals Antibodies, Monoclonal/metabolism Antigens, Neoplasm/metabolism Humans Immunohistochemistry Immunophenotyping Lung Neoplasms/metabolism,pathology,secondary Male Melanoma/immunology,metabolism,secondary Mice Mice, Inbred BALB C Mice, Nude Neoplasm Metastasis/immunology Neoplasm Transplantation Transplantation, Heterologous Tumor Cells, Cultured
Chemicals
Antibodies, Monoclonal Antigens, Neoplasm
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Van Muijen G N
Department of Pathology, University Hospital Nijmegen, The Netherlands.
Cornelissen L M
Jansen C F
Figdor C G
Johnson J P
Bröcker E B
Ruiter D J
References (34)
34 references, click to expand
  1. Phenotypic dynamics of tumor progression in human malignant melanoma.
    Int J Cancer. 1985 Jul 15;36(1):29-35 PMID: 3860479
  2. Enzyme-labeled antibodies: preparation and application for the localization of antigens.
    J Histochem Cytochem. 1966 Dec;14(12):929-31 PMID: 17121392
  3. Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice.
    Cancer Res. 1981 Feb;41(2):438-44 PMID: 7448788
  4. Surface antigens of human melanoma cells defined by monoclonal antibodies. I. Biochemical characterization of two antigens found on cell lines and fresh tumors of diverse tissue origin.
    Eur J Immunol. 1981 Oct;11(10):825-31 PMID: 6895502
  5. Interferon gamma regulates HLA-D expression on solid tumors in vivo.
    Eur J Cancer Clin Oncol. 1987 Jan;23(1):101-6 PMID: 3109920
  6. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Cancer Res. 1989 Sep 15;49(18):5091-6 PMID: 2548711
  7. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma.
    Cancer Res. 1988 Feb 15;48(4):1019-25 PMID: 3338074
  8. Supernatants of human leukocytes contain mediator, different from interferon gamma, which induces expression of MHC class II antigens.
    J Exp Med. 1986 Jul 1;164(1):131-43 PMID: 2941512
  9. Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin.
    Hum Immunol. 1986 Feb;15(2):220-33 PMID: 3081470
  10. Characterization of melanoma-associated surface antigens involved in the adhesion and motility of human melanoma cells.
    Int J Cancer. 1986 Oct 15;38(4):465-73 PMID: 2428758
  11. Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay.
    J Immunol Methods. 1982 Oct 15;54(1):9-22 PMID: 6183366
  12. Tumorigenicity and dissemination of primary and metastatic human melanomas implanted into different sites in athymic nude mice.
    Invasion Metastasis. 1988;8(6):317-31 PMID: 3225146
  13. Monoclonal antibody PAL-M1 recognizes the transferrin receptor and is a progression marker in melanocytic lesions.
    J Invest Dermatol. 1990 Jul;95(1):65-9 PMID: 2366002
  14. Dissociation of cellular responses to epidermal growth factor using anti-receptor monoclonal antibodies.
    EMBO J. 1986 Jun;5(6):1187-92 PMID: 3015588
  15. Establishment and characterization of a human melanoma cell line (MV3) which is highly metastatic in nude mice.
    Int J Cancer. 1991 Apr 22;48(1):85-91 PMID: 2019461
  16. Profile of intercellular adhesion molecule-1 (ICAM-1) synthesized by human melanoma cell lines.
    Semin Oncol. 1988 Dec;15(6):595-607 PMID: 3061012
  17. c-myc down-regulates class I HLA expression in human melanomas.
    EMBO J. 1988 Apr;7(4):1023-9 PMID: 3402430
  18. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon.
    J Immunol. 1987 Sep 15;139(6):2088-95 PMID: 3114385
  19. Discrimination between benign and malignant cells of melanocytic lineage by two novel antigens, a glycoprotein with a molecular weight of 113,000 and a protein with a molecular weight of 76,000.
    Cancer Res. 1987 Feb 1;47(3):841-5 PMID: 3542195
  20. Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.
    J Exp Med. 1984 Jul 1;160(1):255-69 PMID: 6204001
  21. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
    Cancer Res. 1989 Jun 1;49(11):2980-7 PMID: 2497970
  22. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis.
    Cell. 1978 May;14(1):9-20 PMID: 667938
  23. Exceptional lethality for nude mice of cells derived from a primary human melanoma.
    Cancer Res. 1985 Jan;45(1):345-50 PMID: 3965144
  24. Generation of stable cellular phenotypes in a human malignant cell line conditioned by alterations in the cellular microenvironment.
    Cancer Res. 1986 Feb;46(2):940-9 PMID: 3484432
  25. A tumor-associated antigen expressed in melanoma cells with lower malignant potential.
    Int J Cancer. 1985 Jun 15;35(6):787-91 PMID: 3891640
  26. Preferential sites of growth of human tumors in nude mice following subcutaneous transplantation.
    Cancer Res. 1980 Dec;40(12):4509-11 PMID: 7438084
  27. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    J Immunol. 1985 Jun;134(6):4226-30 PMID: 2985706
  28. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications.
    Cancer Surv. 1988;7(4):597-629 PMID: 3072068
  29. A monoclonal antibody specific for cells of the melanocyte lineage.
    Am J Pathol. 1988 Jan;130(1):179-92 PMID: 3276209
  30. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis.
    Proc Natl Acad Sci U S A. 1989 Jan;86(2):641-4 PMID: 2643120
  31. Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.
    J Invest Dermatol. 1985 Jul;85(1):4-8 PMID: 3891875
  32. Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes.
    Int J Cancer. 1987 Apr 15;39(4):466-71 PMID: 3104215
  33. Detection of phenotypic differences on human malignant melanoma lines and their variant sublines with monoclonal antibodies.
    Cancer Immunol Immunother. 1983;15(3):200-5 PMID: 6555061
  34. Establishment of an ascitic human melanoma cell line that metastasizes to lung and liver in nude mice.
    J Cancer Res Clin Oncol. 1984;108(2):197-203 PMID: 6470027
Article Info
Journal
Clinical & experimental metastasis
Abbr.
Clin Exp Metastasis
ISSN
0262-0898
Published
1991-00-00
Pages
259-72
Language
English
Region
Netherlands
NLM ID
8409970
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com